NCT06333951 2026-02-19
AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).
Amgen
Phase 1 Recruiting
Amgen
NYU Langone Health
Amgen
Amgen
City of Hope Medical Center
Vitrac Therapeutics, LLC
Ningbo Newbay Technology Development Co., Ltd
Karolinska University Hospital
Amgen
Erasca, Inc.